Literature DB >> 18209865

Subclinical Cushing's syndrome.

Massimo Terzolo1, Silvia Bovio, Anna Pia, Giangiacomo Osella, Giorgio Borretta, Alberto Angeli, Giuseppe Reimondo.   

Abstract

Subclinical Cushing's syndrome (CS) is attracting increasing interest since the serendipitous discovery of an adrenal mass has become a rather frequent event owing to the routine use of sophisticated radiologic techniques. Cortical adenoma is the most frequent type of adrenal incidentaloma accounting for approximately 50% of cases in surgical series and even greater shares in medical series. Incidentally discovered adrenal adenomas may secrete cortisol in an autonomous manner that is not fully restrained by pituitary feedback, in 5 to 20% of cases depending on study protocols and diagnostic criteria. The criteria for qualifying subclinical cortisol excess are controversial and presently there is no consensus on a gold standard for the diagnosis of this condition. An increased frequency of hypertension, central obesity, impaired glucose tolerance, diabetes and hyperlipemia has been described in patients with subclinical CS; however, there is still no clear demonstration of the long-term complications of this condition whose management remains largely empirical. Either adrenalectomy or careful observation associated with treatment of the metabolic syndrome have been suggested as treatment options.

Entities:  

Mesh:

Year:  2007        PMID: 18209865     DOI: 10.1590/s0004-27302007000800013

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  11 in total

Review 1.  Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly.

Authors:  M G Baroni; F Giorgino; V Pezzino; C Scaroni; A Avogaro
Journal:  J Endocrinol Invest       Date:  2015-12-30       Impact factor: 4.256

2.  Adrenal lesions in acromegaly: do metabolic aspects and aryl hydrocarbon receptor interacting protein gene have a role? Evaluation at baseline and after long-term follow-up.

Authors:  F Ceccato; G Occhi; N M Albiger; S Rizzati; S Ferasin; G Trivellin; F Mantero; C Scaroni
Journal:  J Endocrinol Invest       Date:  2010-07-01       Impact factor: 4.256

3.  Clinically silent adrenal adenomas - their relation to the metabolic syndrome and to GNB3 C825T gene polymorphism.

Authors:  Ivica Lazúrová; Daniela Spišáková; Hedviga Wagnerová; Viera Habalová; Ingrid Dravecká; Petrášová Darina; Ivica Drahovská; Lýdia Pundová
Journal:  Wien Klin Wochenschr       Date:  2011-10-10       Impact factor: 1.704

4.  Predictive value of retroperitoneal fat area measurement for detecting metabolic syndrome in patients undergoing adrenalectomy.

Authors:  Feyzullah Ersöz; Yeşim Erbil; Serkan Sarı; Artür Salmaslıoğlu; Halim Işsever; Ferihan Aral; Selçuk Özarmağan
Journal:  World J Surg       Date:  2011-05       Impact factor: 3.352

Review 5.  Is metabolic syndrome a mild form of Cushing's syndrome?

Authors:  Armand Krikorian; Mehreen Khan
Journal:  Rev Endocr Metab Disord       Date:  2010-06       Impact factor: 6.514

6.  Laparoscopic adrenalectomy in patients with subclinical Cushing syndrome.

Authors:  Iraklis Perysinakis; Chrisanthi Marakaki; Spyridon Avlonitis; Anastasia Katseli; Evangeline Vassilatou; Lambrini Papanastasiou; George Piaditis; George N Zografos
Journal:  Surg Endosc       Date:  2013-01-26       Impact factor: 4.584

7.  Unrecognized adrenal insufficiency in patients undergoing laparoscopic adrenalectomy.

Authors:  Jamie Mitchell; German Barbosa; Michael Tsinberg; Mira Milas; Allan Siperstein; Eren Berber
Journal:  Surg Endosc       Date:  2008-11-27       Impact factor: 4.584

8.  Treatment Options in Cushing's Disease.

Authors:  Ahmed Rizk; Juergen Honegger; Monika Milian; Tsambika Psaras
Journal:  Clin Med Insights Oncol       Date:  2012-01-11

9.  Is it worthwhile to screen patients with type 2 diabetes mellitus for subclinical Cushing's syndrome?

Authors:  Sweta Budyal; Swati Sachin Jadhav; Rajeev Kasaliwal; Hiren Patt; Shruti Khare; Vyankatesh Shivane; Anurag R Lila; Tushar Bandgar; Nalini S Shah
Journal:  Endocr Connect       Date:  2015-09-29       Impact factor: 3.335

Review 10.  Adrenalectomy for Cushing's syndrome: do's and don'ts.

Authors:  D N Paduraru; A Nica; M Carsote; A Valea
Journal:  J Med Life       Date:  2016 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.